8
Oct
2024

Luohe Chief Pharmaceutical Co., Ltd.

Exhibitor at CPHI Milan 2024 stand 4D1, API
About Us

Founded in 2013, Luohe Chief Pharmaceutical Co. Ltd. is a high-tech enterprise, focusing on the research and development, production and sales of APIs and intermediates. We're featured with Rifamycin series products, specializing in the production of Rifamycin S, Rifampicin, Rifaximin, Rifabutin, Rifapentine,Rifamycin Sodium and other products in a large scale. USDMFs and CEPs for Rifamycin series products have already been submitted, and registration in Europe, USA and other countries and regions has been completed.

  • CN
  • 2018
    On CPHI since
  • 100 - 249
    Employees
Company types
CMO/CDMO
Other
Pharmaceutical company
Contact info
  • NO.168, Longjiang Road,Yancheng District, 462300, Luohe, China
Event information
CPHI Milan 2024
  • 08 Oct 2024 - 10 Oct 2024
  • Fiera Milano, Italy
  • Visit us at stand 4D1, API

Products Featured at CPHI Milan 2024

  • RIFABUTIN

    Product RIFABUTIN

    Rifabutin: Amorphous red-purple powder, an active ingredient used to treat tuberculosis, Helicobacter pylori and the mycobacterium avium complex.CAS:72559-06-9
    Specification:EP/USP
    Packing:15Kg/Drum
    Documents:DML, WC, DMF, CEP, USDMF
  • RIFAMPICIN

    Product RIFAMPICIN

    Rifmpicin: Red to brownish-red crystalline powder, an active ingredient used to treat tuberculosis.
  • RIFAXIMIN

    Product RIFAXIMIN

    Rifaximin: Red-orange crystalline powder, an antibiotic used to treat traveler's diarrhea, irritable bowel syndrome and hepatic encephalopathy.
  • RIFAMYCIN  SODIUM

    Product RIFAMYCIN SODIUM

    Rifamycin Sodium: Fine or granular red powder, an active ingredient used to treat tuberculosis, travelers' diarrhea.
  • RIFAPENTINE

    Product RIFAPENTINE

    Rifapentine: Dark red to reddish-brown crystalline powder, an antibiotic used to treat tuberculosis.